Inspire Medical Systems (NYSE:INSP) Shares Down 5.4% - What's Next?

Key Points

• Inspire Medical Systems shares fell 5.4% to about $71.63 in midday trading, with volume roughly 47% below the average.
• Analyst sentiment remains mixed: the stock has an average “Hold” rating and a consensus price target of $66.50, despite several firms recently raising targets and ratings.
• The company exceeded quarterly earnings and revenue expectations, reporting $0.14 in EPS and $200.58 million in revenue, though revenue declined 7.6% year over year. Institutional investors own approximately 94.91% of outstanding shares.

Inspire Medical Systems, Inc. (NYSE:INSP - Get Free Report) was down 5.4% during mid-day trading on Tuesday . The company traded as low as $71.62 and last traded at $71.6260. Approximately 577,956 shares were traded during mid-day trading, a decline of 47% from the average daily volume of 1,081,862 shares. The stock had previously closed at $75.72.

Analyst Ratings Changes

A number of research firms recently weighed in on INSP. Mizuho raised their target price on shares of Inspire Medical Systems from $55.00 to $65.00 and gave the company an "outperform" rating in a research report on Tuesday, August 4th. Zacks Research upgraded shares of Inspire Medical Systems from a "hold" rating to a "strong-buy" rating in a research note on Monday, August 17th. Stifel Nicolaus lifted their target price on Inspire Medical Systems from $75.00 to $80.00 and gave the company a "buy" rating in a research report on Friday, September 11th. KeyCorp reissued a "sector weight" rating on shares of Inspire Medical Systems in a research report on Tuesday, August 4th. Finally, Piper Sandler boosted their price target on Inspire Medical Systems from $55.00 to $60.00 and gave the stock a "neutral" rating in a research report on Tuesday, August 4th. Two research analysts have rated the stock with a Strong Buy rating, three have assigned a Buy rating, eleven have given a Hold rating and three have given a Sell rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $66.50.

Inspire Medical Systems Price Performance

The stock has a 50-day moving average price of $59.97 and a 200-day moving average price of $53.08. The company has a market capitalization of $2.07 billion, a price-to-earnings ratio of 15.52, a PEG ratio of 5.84 and a beta of 0.70.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last released its quarterly earnings data on Monday, August 3rd. The company reported $0.14 EPS for the quarter, topping analysts' consensus estimates of ($0.24) by $0.38. The firm had revenue of $200.58 million during the quarter, compared to analysts' expectations of $194.72 million. Inspire Medical Systems had a net margin of 15.03% and a return on equity of 8.64%. The company's revenue for the quarter was down 7.6% compared to the same quarter last year. During the same period in the previous year, the business posted $0.45 earnings per share. Inspire Medical Systems has set its FY 2026 guidance at 1.050-1.450 EPS. Equities analysts forecast that Inspire Medical Systems, Inc. will post 1.24 earnings per share for the current year.

Insider Transactions at Inspire Medical Systems

In other news, insider Jason Kelly sold 963 shares of the company's stock in a transaction that occurred on Friday, August 7th. The stock was sold at an average price of $59.55, for a total value of $57,346.65. Following the transaction, the insider owned 18,985 shares of the company's stock, valued at approximately $1,130,556.75. This represents a 4.83% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 2.20% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in INSP. Alberta Investment Management Corp acquired a new stake in shares of Inspire Medical Systems during the 2nd quarter worth $5,483,000. GSA Capital Partners LLP bought a new stake in shares of Inspire Medical Systems during the 2nd quarter worth approximately $820,000. Assenagon Asset Management S.A. boosted its position in shares of Inspire Medical Systems by 66.2% during the 2nd quarter. Assenagon Asset Management S.A. now owns 864,395 shares of the company's stock worth $38,561,000 after acquiring an additional 344,221 shares in the last quarter. Bank of Nova Scotia increased its stake in Inspire Medical Systems by 49.8% in the first quarter. Bank of Nova Scotia now owns 60,000 shares of the company's stock valued at $3,095,000 after acquiring an additional 19,958 shares during the last quarter. Finally, Legal & General Group Plc bought a new position in Inspire Medical Systems in the second quarter valued at approximately $2,732,000. 94.91% of the stock is owned by institutional investors and hedge funds.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc develops and commercializes medical devices for treating moderate to severe obstructive sleep apnea (OSA), a condition in which the upper airway repeatedly becomes blocked during sleep. The company's primary product is Inspire therapy, an implantable system designed for patients who are unable to use or obtain consistent benefit from continuous positive airway pressure (CPAP) therapy.

The Inspire system uses a small implantable pulse generator, a breathing-sensing lead and a stimulation lead.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.